Treatment of urogenital tuberculosis with terivalidin.
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003558:Cystoscopy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007097:Imines / Q000008:administration & dosage / Q000627:therapeutic use; D007538:Isoniazid / Q000627:therapeutic use; D007668:Kidney / Q000503:physiopathology; D007682:Kidney Pelvis / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D009392:Nephrectomy; D010080:Oxazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D011776:Pyuria / Q000150:complications / Q000188:drug therapy; D011859:Radiography; D013307:Streptomycin / Q000627:therapeutic use; D014398:Tuberculosis, Renal / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D014401:Tuberculosis, Urogenital / Q000150:complications / Q000188:drug therapy*; D014515:Ureteral Diseases / Q000601:surgery
D000636:Aminosalicylic Acids; D000892:Anti-Infective Agents, Urinary; D000995:Antitubercular Agents; D007097:Imines; D010080:Oxazoles; D011718:Pyrazinamide; D011239:Prednisolone; D007538:Isoniazid; D013307:Streptomycin